Observational study of lipid profile and LDL particle size in patients with metabolic syndrome
Authors:
- Natalia Sancho-RodríguezNSNatalia Sancho-Rodríguez
- Francisco V Avilés-PlazaFAFrancisco V Avilés-Plaza
- Esteban Granero-FernándezEGEsteban Granero-Fernández
- Antonio M Hernández-MartínezAHAntonio M Hernández-Martínez
- María Dolores Albaladejo-OtónMAMaría Dolores Albaladejo-Otón
- Soledad Parra-PallarésSPSoledad Parra-Pallarés
Open Access
- 1 January 2011
- journal article
- research article
- Published by Springer Nature in Lipids in Health and Disease
- Vol. 10 (1) , 162
Abstract
The atherogenic lipoprotein phenotype is characterized by an increase in plasma triglycerides, a decrease in high-density lipoprotein cholesterol (HDLc), and the prevalence of small, dense-low density lipoprotein cholesterol (LDLc) particles. The aim of this study was to establish the importance of LDL particle size measurement by gender in a group of patients with Metabolic Syndrome (MS) attending at a Cardiovascular Risk Unit in Primary Care and their classification into phenotypes. One hundred eighty-five patients (93 men and 92 women) from several areas in the South of Spain, for a period of one year in a health centre were studied. Laboratory parameters included plasma lipids, lipoproteins, low-density lipoprotein size and several atherogenic rates were determinated. We found differences by gender between anthropometric parameters, blood pressure and glucose measures by MS status. Lipid profile was different in our two study groups, and gender differences in these parameters within each group were also remarkable, in HDLc and Apo A-I values. According to LDL particle size, we found males had smaller size than females, and patients with MS had also smaller than those without MS. We observed inverse relationship between LDL particle size and triglycerides in patients with and without MS, and the same relationship between all atherogenic rates in non-MS patients. When we considered our population in two classes of phenotypes, lipid profile was worse in phenotype B. In conclusion, we consider worthy the measurement of LDL particle size due to its relationship with lipid profile and cardiovascular risk.Keywords
This publication has 29 references indexed in Scilit:
- Factors influencing the formation of small dense low-density lipoprotein particles in dependence on the presence of the metabolic syndrome and on the degree of glucose intoleranceInternational Journal Of Clinical Practice, 2007
- Does Low-Density Lipoprotein Size Add to Atherogenic Particle Number in Predicting the Risk of Fatal Myocardial Infarction?The American Journal of Cardiology, 2006
- Should we measure routinely the LDL peak particle size?International Journal of Cardiology, 2006
- The Global Burden of Chronic DiseasesJAMA, 2004
- A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarctionJAMA, 1996
- Small, dense low density lipoproteins, the insulin resistance syndrome and noninsulin-dependent diabetesCurrent Opinion in Lipidology, 1996
- Lipid and Lipoprotein Factors Associated With Variation in Lp(a) DensityArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Characterization of low-density lipoprotein subclassesCurrent Opinion in Lipidology, 1994
- Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease riskAtherosclerosis, 1994
- Inheritance of low density lipoprotein subclass patterns in familial combined hyperlipidemia.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1990